Alyeska Investment Group
CYTK icon

Alyeska Investment Group’s Cytokinetics CYTK Stock Holding History

Alyeska Investment Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-50,607
Closed -$339K – 402
2015
Q3 		$339K Hold
50,607
– – ﹤0.01% 437
2015
Q2 		$340K Hold
50,607
– – ﹤0.01% 468
2015
Q1 		$343K Sell
50,607
-15,182
-23% -$113K ﹤0.01% 479
2014
Q4 		$527K Hold
65,789
– – 0.01% 438
2014
Q3 		$232K Hold
65,789
– – ﹤0.01% 367
2014
Q2 		$314K Hold
65,789
– – 0.01% 386
2014
Q1 		$1.04M Sell
65,789
-328,947
-83% -$2.98M 0.03% 293
2013
Q4 		$2.57M Hold
394,736
– – 0.1% 219
2013
Q3 		$2.99M Hold
394,736
– – 0.12% 191
2013
Q2 		$4.57M Buy
+394,736
New +$3.11M 0.22% 134

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alyeska Investment Group's CYTK Position: Q1 2026 in Review

Alyeska Investment Group opened a new position in Cytokinetics (CYTK) in Q1 2026: 150,000 shares worth $9.89M. The stake represents 0.03% of the portfolio and ranks #400 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in CYTK as recently as Q1 2025.

Alyeska Investment Group first reported a position in CYTK in Q2 2013 and has held it in 14 quarters since. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Alyeska Investment Group held 150,000 shares of Cytokinetics worth $9.89M as of Q1 2026.
  • Cytokinetics was a new Alyeska Investment Group position in Q1 2026.
  • Cytokinetics made up 0.03% of Alyeska Investment Group's portfolio in Q1 2026, its #400 holding.
  • Alyeska Investment Group first reported a position in Cytokinetics in Q2 2013 and has held it in 14 quarters since.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.